Clearance deficiency and systemic lupus erythematosus (SLE).

Systemic lupus erythematosus (SLE) is a fairly heterogeneous autoimmune disease. Impaired clearance functions for dying cells may explain accumulation of nuclear autoantigens in various tissues of SLE patients. Our data show that in a subgroup of patients with SLE, apoptotic cells accumulated in the germinal centres of the lymph nodes. Apoptotic material was attached to the surfaces of follicular dendritic cells. Furthermore, we found an accumulation of apoptotic cells in the skin of patients with cutaneous lupus after UV exposure. Granulocytes and monocytes in whole blood of SLE patients showed a reduced uptake of albumin- and polyglobin-coated beads. Furthermore, we analysed sera from SLE patients in migration assays and observed that the attraction signals for macrophages were reduced by sera of approximately 25% of the SLE patients. Analyses of high-affinity DNA binding IgG autoantibodies of SLE patients revealed that those antibodies had gained their DNA reactivity in a germinal centre reaction. We suggest a stepwise maturation from a non-anti-DNA reactive B cell to an anti-dsDNA autoreactive B cell. We conclude that impaired clearance in early phases of apoptosis leads to a secondary necrotic status of the cells. Danger signals are released; modified autoantigens are accessible, favouring an autoimmune reaction.

[1]  C. Lau,et al.  Pathogenesis of systemic lupus erythematosus , 2003, Journal of clinical pathology.

[2]  C. Janeway.  Immunobiology: The Immune System in Health and Disease , 1996 .

[3]  M. Botto.  Links between complement deficiency and apoptosis , 2001, Arthritis research.

[4]  E. Ballestar,et al.  The Epigenetic Face of Systemic Lupus Erythematosus1 , 2006, The Journal of Immunology.

[5]  J. Harley,et al.  Serologic studies of monozygotic twins with systemic lupus erythematosus. , 1992, Arthritis and rheumatism.

[6]  P. Heyder,et al.  Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. , 2004, Arthritis and rheumatism.

[7]  M. Sticherling,et al.  Clinical Manifestations of Cutaneous Lupus Erythematosus , 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[8]  M. Walport,et al.  C1q and systemic lupus erythematosus. , 1998, Immunobiology.

[9]  C. Kallenberg,et al.  Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus? , 2006, Arthritis research & therapy.

[10]  E. Tan,et al.  Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus , 2004, Rheumatology International.

[11]  A. Perl,et al.  Endogenous retroviruses: potential etiologic agents in autoimmunity , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  Y. Shoenfeld,et al.  The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. , 2005, Immunobiology.

[13]  R. Voll,et al.  Impaired clearance of dying cells in systemic lupus erythematosus. , 2005, Autoimmunity reviews.

[14]  H. Yoshikawa,et al.  Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages , 2006, Nature.

[15]  T. Winkler,et al.  IgG human monoclonal anti‐DNA autoantibodies from patients with systemic lupus erythematosus , 1991, Clinical and experimental immunology.

[16]  A. Martin-Villalba,et al.  Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. , 2006, Arthritis and rheumatism.

[17]  F. Furukawa,et al.  Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. , 1990, The Journal of investigative dermatology.

[18]  J. Whittaker,et al.  Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. , 2003, Human molecular genetics.

[19]  G. F. Burton,et al.  Tinigible Body Macrophages in Regulation of Germinal Center Reactions , 1998, Developmental immunology.

[20]  G. Murphy,et al.  The molecular determinants of sunburn cell formation , 2001, Experimental dermatology.

[21]  C. Haslett,et al.  Regulation of macrophage phagocytosis of apoptotic cells by cAMP. , 1998, Journal of immunology.

[22]  I. Baumann,et al.  Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[23]  P. Krammer,et al.  Pathophysiology of cutaneous lupus erythematosus--novel aspects. , 2006, Rheumatology.

[24]  John C Hall,et al.  Altered structure of autoantigens during apoptosis. , 2004, Rheumatic diseases clinics of North America.

[25]  Brian A. Smith,et al.  Histidine-Rich Glycoprotein Binds to DNA and FcγRI and Potentiates the Ingestion of Apoptotic Cells by Macrophages1 , 2002, The Journal of Immunology.

[26]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[27]  Jonathan K. H. Tan,et al.  Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity , 2005, Journal of leukocyte biology.

[28]  T. Ruzicka,et al.  Cutaneous lupus erythematosus , 2004 .

[29]  M. Walport,et al.  Predominant role of IgM‐dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow‐derived macrophages in vitro , 2005, European journal of immunology.

[30]  D. Mevorach,et al.  Complement-dependent Clearance of Apoptotic Cells by Human Macrophages , 1998, The Journal of experimental medicine.

[31]  T. Sundt,et al.  Stereospecific chemoattraction of lymphoblastic cells by gradients of lysophosphatidylcholine. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Hart,et al.  Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. , 2003, Clinical science.

[33]  N. Brot,et al.  C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response , 2000, The Journal of experimental medicine.

[34]  P. Ricciardi-Castagnoli,et al.  Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. , 1998, Journal of immunology.

[35]  B. Svensson.  Occurrence of deficient monocyte yeast cell phagocytosis in presence of rheumatic sera. , 1980, Scandinavian journal of rheumatology. Supplement.

[36]  C. Lau,et al.  Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. , 2003, Arthritis and rheumatism.

[37]  R. Voll,et al.  Clearance of apoptotic cells in human SLE. , 2006, Current directions in autoimmunity.

[38]  R. Voll,et al.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[39]  P. Matzinger,et al.  Danger signals: SOS to the immune system. , 2001, Current opinion in immunology.

[40]  T. Winkler,et al.  The evolution of human anti-double-stranded DNA autoantibodies. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Voll,et al.  Inefficient clearance of dying cells and autoreactivity. , 2006, Current topics in microbiology and immunology.

[42]  S. Baksh,et al.  Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal , 2003, Cell.

[43]  J. McConnell,et al.  Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity , 2001, Annals of the rheumatic diseases.

[44]  R. Voll,et al.  Removal of dying cells and systemic lupus erythematosus , 2005, Modern rheumatology.

[45]  J. Kalden,et al.  Analysis of immunoglobulin variable region genes from human IgG anti‐DNA hybridomas , 1992, European journal of immunology.

[46]  P. Heyder,et al.  Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death , 2001, Cell Death and Differentiation.

[47]  E. Reefman,et al.  Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes. , 2006, Rheumatology.

[48]  E. Beutner,et al.  Diagnosis of Systemic Lupus Erythematosus: Importance of Antinuclear Antibody Titers and Peripheral Staining Patterns , 1975 .

[49]  M. Mattioli,et al.  Antinuclear antibodies (ANA): immunologic and clinical significance. , 1976, Seminars in arthritis and rheumatism.

[50]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[51]  R. Voll,et al.  Impaired clearance of apoptotic cells in systemic lupus erythematosus: Challenge of T and B cell tolerance , 2003, Current rheumatology reports.

[52]  A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. , 2000 .

[53]  Y. Shoshan,et al.  Accelerated Fas-Mediated Apoptosis of Monocytes and Maturing Macrophages from Patients with Systemic Lupus Erythematosus: Relevance to In Vitro Impairment of Interaction with iC3b-Opsonized Apoptotic Cells1 , 2001, The Journal of Immunology.